Acadia Pharmaceuticals Inc. (ACAD)

Last Three Months

29-Jun-23 -- 28-Sep-23

Time Period:
  • Three Months
  •  | 
  • Year

0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Strong Buy
Insider Trading Sentiment: Strong Buy
Sentiment Breakdown by Insider
0
(3)
0
(2)
3
(1)
30
0
0
+1
0
+2
0
+3

Two Year Chart

29-Sep-21 -- 28-Sep-23

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
18-Jul-23 6:00 PM
View: 
14-Jul-23
Planned Private Option Sale
($3.00M)
Davis Stephen
CEO
Director
Insider Trading Sentiment for Davis Stephen at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD(66%)
108.3K to 36.7K
0
0
---- Show TxnsShow Insider Trades
19-Sep-23 6:31 PM
View: 
15-Sep-23
Private Sale (Planned)
($51.76K)
Kihara James
Principal Accounting Officer
Insider Trading Sentiment for Kihara James at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD(16%)
12.78K to 10.78K
0
0
---- Show TxnsShow Insider Trades
23-Aug-23 7:31 PM
View: 
21-Aug-23
Private Sale (Planned)
($289.97K)
Schneyer Mark C.
EVP, Chief Financial Officer
Insider Trading Sentiment for Schneyer Mark C. at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD(39%)
25.68K to 15.68K
0
0
---- Show TxnsShow Insider Trades